Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)

NCT02365909 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Study stopped due to difficulty recruiting patients

Conditions

Postdural Puncture Headache

Interventions

DRUG: 0.5% bupivacaine
DRUG: normal saline

Sponsor

University of Arkansas